Clinical Trial Update: Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial update for leronlimab in moderately ill COVID-19 pneumonia patients; study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: COVID-19 Pneumonia | Phase 3 | Status: SUSPENDED